Mythralica SRL
Mythralica reported total assets of 135,553 € at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Jul 2026).
The score of Mythralica shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Mythralica's annual accounts
| 2025 | |
|---|---|
| Net result | −19,173 € |
| Equity | 130,827 € |
| Cash | 90,600 € |
| EBITDA | −18,106 € |
| Total assets | 135,553 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Jul 2026
Mythralica's financial analysis
- Solvency96.5%sector median: 41.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Mythralica
Mythralica's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1023.528.855
- VAT number
- BE1023528855
- Peppol
- Registered · 0208:1023528855 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 May 2025
- Registered office
- 1040 Etterbeek
- Latest accounts
- 2025 · filed on 02 Jul 2026
- Activity
- Manufacture of other pharmaceutical products (NACE 21209)
Mythralica (SRL) has been based in Etterbeek since 2025, active in: manufacture of other pharmaceutical products. For 2025, it reports a net loss of 19,173 € and equity of 130,827 €; its revenue is not published. Its solvency stands at 96.5%, above the median of its sector (41.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Mythralica
Companies in the same business, of comparable size and area, outside its group.
- Attito Management Manufacture of pharmaceutical preparations Kapelle-op-den-Bos · balance sheet 131,498 €
- Make IT Work Consulting Manufacture of basic pharmaceutical products Hamois · balance sheet 220,980 €
- L - Pharma Manufacture of pharmaceutical preparations Turnhout · balance sheet 10 €
- RTLC Manufacture of pharmaceutical preparations Brussels · balance sheet 107,167 €
- Taikun Pharmaceutical Technology Manufacture of basic pharmaceutical products Ghent · balance sheet 275,396 €
- AdipoPharma Belgique Manufacture of pharmaceutical preparations Charleroi · balance sheet 398,195 €
- Clinical Research Vanackere Manufacture of basic pharmaceutical products Tielt-Winge · balance sheet 263,927 €
- Biomdrin Manufacture of pharmaceutical preparations Schilde · balance sheet 38,268 €
Frequently asked questions about Mythralica
What is the revenue of Mythralica?
Mythralica files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Mythralica?
In Belgium, the VAT number is the company number prefixed with BE: BE1023528855 for Mythralica, if the company is VAT-registered. Its company number (CBE) is 1023.528.855.
Where is the registered office of Mythralica?
According to the CBE register, the registered office of Mythralica is in 1040 Etterbeek.
What is the equity of Mythralica?
At the close of the 2025 financial year, the equity of Mythralica amounts to 130,827 €, a solvency of 96.5% of total assets.
Who manages Mythralica?
The register lists 1 active mandates at Mythralica. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Mythralica
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →